Individuals with CD1E*01/01 genotype have an increased likelihood of developing GBS while those with a CD1A*01/02, CD1E*01/02, or both have a decreased chance in developing GBS (Caporale et al., 2006a). This evidence concerns the gene CD1E and Guillain-Barre syndrome.